CLDF Title
Home | Contact Us | Bookmark
MASH HCC ALCOHOL LIVER DISEASE PEDIATRIC LIVER DISEASE
Embassy of Education
Webcasts Abstract Library LiverQ Academy National Conference Regional Conferences
 
Back  
 
Reuters Health Information (2008-03-06): Salmonella strain shows antitumor activity in animal model

Science

Salmonella strain shows antitumor activity in animal model

Last Updated: 2008-03-06 13:48:24 -0400 (Reuters Health)

NEW YORK (Reuters Health) - Injections of Salmonella choleraesuis slow tumor growth and prolong survival in a murine model of orthotopic hepatocellular carcinoma, Taiwanese researchers report in the February 15 issue of the International Journal of Cancer.

Dr. Che-Hsin Lee and colleagues at National Cheng Kung University Medical College in Tainan note that in previous research they demonstrated that an attenuated vaccine strain of S. choleraesuis targets tumors and is oncolytic in subcutaneous tumors. However, this "may not necessarily indicate efficacy against orthotopic tumors," they explain.

To explore further, the team administered S. choleraesuis systemically to mice bearing both subcutaneous and orthotopic hepatocellular carcinoma tumors. The bacteria rapidly accumulated within the tumors, with tumor-to-normal tissue ratios exceeding 1,000-10,000 to 1, for at least 30 days.

Compared with controls with untreated tumors, S. choleraesuis "significantly prolonged the animal survival, reduced the tumor size, as well as upregulated interferon (IFN)-gamma," Dr. Lee and associates report. This in turn stimulated production of the IFN-inducible chemokines.

Immunohistochemical staining of the tumors showed decreased microvessel density, increased infiltration of neutrophils, the presence of CD4 and CD8 T-cells, and induced cell death in the tumor microenvironment.

Dr. Lee's team writes: "These results suggest that tumor-targeted therapy using S. choleraesuis, which exerts tumoricidal and antiangiogenic activities, represents a potential strategy for the treatment of hepatocellular carcinoma."

Int J Cancer 2008;122:930-935.

 
 
 
 

Subscribe

Be the first to know about our latest upcoming programs and events!

CLDF

Follow us

The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2025 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.